View all cases
UPC CFI 40/2025
Jan 22, 2025·EP3167888 +1 more: TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
- Case details
- StatusCase ClosedActionGenericCategoryCosts Assessments
- Parties
- Division
- Hamburg LD
- Technology
- Organic Chemistry
- Language
- —
Decisions
- 2025-08-01Costs onlyApplication For Costs
Decision of Hamburg Local Division in Samsung Bioepis NL B.V. v Alexion Pharmaceuticals (EP 3 167 888) assessing the costs of appeal proceedings following the Court of Appeal's rejection (20 December 2024) of Alexion's appeal against the dismissal of its application for provisional measures against Samsung Bioepis' Epysqli biosimilar. The court allowed the costs for UPC representatives and patent attorneys but reduced costs claimed for UK solicitors whose involvement (at higher cost than the actual UPC representatives) was not demonstrated to be necessary.
Legal issues:Costs assessment for appeal proceedings under R. 150-152 RoPNecessity and proportionality of UK solicitors' costs in UPC proceedingsCeiling for recoverable costs
Documents
| Document title | Date | Public |
|---|---|---|
| Application-For-Costs-Decision-Outcome | 2025-08-05 | Not public |
| Headnote-and-Keywords | 2025-08-01 | Not public |
| Order with grounds | 2025-08-01 | Not public |
| Order with grounds | 2025-08-01 | Public |
| Order with grounds | 2025-08-01 | Public |
| Order with grounds | 2025-08-01 | Not public |
| Receipt | 2025-07-23 | Not public |
| 20250404_Alexion_vs_SB12_EP888_UPC_CFI_40_2025_Further_comment_defendant_Redacted | 2025-07-23 | Not public |
| 20250120_SB12_UPC_Alexion_vs_SB_EP888-request_for_cost_recovery_Redacted | 2025-07-23 | Not public |
| Exhibit_S_S_01 | 2025-07-23 | Not public |
| Exhibit_S_S_03 | 2025-07-23 | Not public |
| Exhibit_S_S_04 | 2025-07-23 | Not public |
| Exhibit_S_S_02 | 2025-07-23 | Not public |
| 20250723_Alexion_vs_SB12_Request_for_Confidentiality_R_262.2_UPC_CFI_40_2025 | 2025-07-23 | Not public |
| Comments | 2025-07-14 | Not public |
| Exhibit FBD-C 1 | 2025-07-14 | Not public |
| Anhoerung | 2025-07-02 | Not public |
| Exhibit_S_S_03 | 2025-04-04 | Not public |
| Exhibit_S_S_06 | 2025-04-04 | Not public |
| 20250404_Alexion_vs_SB12_EP888_UPC_CFI_40_2025_Further_comment_defendant_re_cost_decision | 2025-04-04 | Not public |
| Exhibit_S_S_05 | 2025-04-04 | Not public |
| Exhibit_S_S_02 | 2025-04-04 | Not public |
| Exhibit_S_S_01 | 2025-04-04 | Not public |
| Exhibit_S_S_04 | 2025-04-04 | Not public |
| Anhoerung | 2025-03-18 | Not public |
| Comments | 2025-03-17 | Not public |
| Anhoerung | 2025-03-07 | Not public |
| Panel-Appointment | 2025-02-04 | Not public |
| Receipt | 2025-01-24 | Not public |
| 20250124_SB12_UPC_Alexion_vs_SB_EP888_Request_for_referral_of_Application_for_costs_to_Court_of_First | 2025-01-24 | Not public |
| Receipt | 2025-01-22 | Not public |
| Acknowledgement-of-lodging | 2025-01-20 | Not public |
| Application for cost recovery | 2025-01-20 | Not public |